Navigation Links
Decision Diagnostic Corp. Clarifies 10% Stock Dividend, Announces Patent Enforcement Strategy
Date:12/27/2011

LOS ANGELES, Dec. 27, 2011 /PRNewswire/ -- Decision Diagnostics Corp., formerly known as InstaCare Corp., (OTCQB: ISCRD), a leading provider of prescription diagnostics, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced that its previously announced 10% Stock Dividend will be Ex-Dividend to all shareholders of record on December 28, 2011.  The Dividend payment date will be December 30, 2011.

Mr. Berman, CFO and Secretary commented, "the stock Dividend is designed to enhance the visibility of the company, improve liquidity, and reward our loyal shareholders.  This Dividend and the changes to the company's capital structure are part of an effort to qualify to have our common stock to be listed on a national exchange, with the goal of applying to the NASDAQ Bx exchange in 2012."

Decision Diagnostics also announced that the company acquired another small engineering oriented company, Sensor Concepts, LLC, an electro-chemistry concepts company.  In addition, the company announced that they have formulated a patent enforcement strategy to coincide with the expected near term grant of the patent for the company's MD@Hand technologies.

Mr. Berman continued, "the Board will continue to evaluate other acquisitions that would add to the company's depth in the at-home diagnostics channel, while we conclude the FDA 510k approval process for Shasta Genstrip. We will have more to say about our new patent enforcement strategies in the coming days."

For more information about Decision Diagnostics Corp. and its revolutionary MD@Hand cell phone centric technologies, and, Pharma Tech Solutions, Inc. and its Shasta Genstrip, please visit the Decision Diagnostics web site www.decisiondiagnostics.com or the Pharma Tech web site www.pharmatechdirect.com, or call the company at (805) 446-2973.

Forward-Looking Statements

This news release contains forward-looking statements about our business, or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions.


'/>"/>
SOURCE Decision Diagnostics Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Catholic Health Association Applauds HHS Decision on Plan B
2. Decision Diagnostic Corp. (Formerly InstaCare) Announces 10% Stock Dividend
3. FDA Commissioner announces Avastin decision
4. Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization
5. Pharmaceutical Executives Use New Search Function for Data-Informed Decision-Making
6. e-Zassi and UBM Canon Partner to Provide Online Medical Device Decision Support Tools at Qmed.com
7. American College of Medical Genetics Applauds HHS Secretarys Decision to Expand Newborn Screening to Include Critical Congenital Heart Disease
8. Experis Recognizes National Healthcare IT Week, Provides Tips for ICD-10 Assessment Decision
9. QIAGEN Completes Second U.S.Submission for Companion Diagnostic to Guide Treatment Decisions in Colorectal Cancer
10. DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting
11. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Feb 17, 2017 Research and Markets has announced ... Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , and Rest of World. Annual estimates ... six-year historic analysis is provided for these markets. Market data and analytics ...
(Date:2/17/2017)... 17, 2017  Featuring new and ... the  2017 HIMSS Conference & Exhibition (HIMSS17 ),  Royal ... global leader in health technology,  will ... population health management, acute healthcare informatics ... a highly secure, cloud-based ecosystem. Visitors ...
(Date:2/16/2017)... Research and Markets has announced the ... Technologies" report to their offering. ... Traditional medical devices include ... non-drug coated implantables, large endoscopes, needle based drug delivery, lab ... last two to three decades for the treatment and management ...
Breaking Medicine Technology:
(Date:2/18/2017)... ... ... Butler Mobility invited Ken Matthews to visit its manufacturing facility and showroom to ... with the safety and reliability of the Stannah Stairlift as well as with the ... by Ken Matthews can be heard on News Radio WHP 580 weekdays from 3:00 ...
(Date:2/18/2017)... ... February 18, 2017 , ... ProParagraph Fashion ... Film Studios ’ ProParagraph Fashion Volume 2 for all multi-line FCPX project needs. ... Users can pick and choose from hand-crafted trend-setting designs with smooth animations that ...
(Date:2/17/2017)... ... February 17, 2017 , ... While EHR data has revolutionized ... an innovative workstation designed to reduce nursing fatigue while enhancing productivity. Based on ... offers a lightweight, highly mobile, multi-functional alternative to the limitations of handheld computing. ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the first ... solution to the exhibit floor for the 2017 HIMSS Conference & Exhibition ... Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action ... Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ... action (CA) and preventive action (PA)? , The methods share techniques and tools ...
Breaking Medicine News(10 mins):